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The need for co-ordinated studies
for obesity-related problems like
diabetes mellitus in Libyan population
O
besity is one of the major risk factors of type 2
diabetes and is associated with many metabolic
derangements that impair insulin sensitivity
(1, 2). These abnormalities include excess lipolysis caus-
ing increased concentrations of non-esterified fatty acids
and triglycerides in blood and skeletal muscle. Muscle
glucose uptake is suppressed.
Figure 1 gives the possible biochemical mechanisms
involved in the evolution of insulin resistance and insulin-
resistant states including diabetes.
Obesity is reported to affect insulin action by changing
the secretion of adipocytokines, specifically of leptin
and adiponectin (3) and leads to proinflammatory
conditions (4). Features of insulin resistance, including
hypertriglyceridaemia and increased abdominal or visc-
eral fat, are seen even in non-obese populations (5).
There is a positive association between body mass index
and glucose intolerance in most of the studies reported
in the literature. Although the WHO body mass index
figure should be retained as an international classifica-
tion, individual countries could make decisions about the
definition of increased risk for their populations (5).
Insulin resistance is associated with visceral and sub-
cutaneous fat content (6). Glucose disposal rate and
plasma adiponectin concentration are inversely related
to fat-cell size (6).
Fatty acid influx to the liver is an important pathoge-
netic factor for fatty liver and is also a determinant
of excess triglyceride-rich lipoproteins. Dyslipidaemia in
type 2 diabetes is more severe in the presence of fatty
liver (7).
Ectopicfataccumulationintheliverandskeletalmuscle
is an important determinant of insulin resistance and
can also predispose to development of type 2 diabetes
(8). The twin cycle hypothesis put forth in a review by
Taylor (9) explains the cycle of reactions linking muscle
insulin resistance, ectopic fat deposition in the liver and
islets, hepatic insulin resistance and b-cell dysfunction,
eventually resulting in the onset of type 2 diabetes (Fig. 2).
Cycle A. Development of fatty liver, which leads to
an increase in plasma glucose levels and basal levels
of insulin in the plasma. Cycle B. Sequences of changes in
tissue when exposed to higher concentration of triacyl-
glycerol that results in decreased response to insulin
following glucose ingestion. Postprandial response to
glucose becomes blunted. These vicious cycles have an
adverse inhibitory effect on islet cell, resulting in the
precipitation of clinical diabetes.
Such pathogenetic mechanisms are cited as possible
mechanisms of insulin resistance and islet cell response
affectedbymaladaptationtomodernisationandaffluence.
Certain populations produce higher amounts of adeno-
sine triphosphate despite being more insulin resistant and
have higher intramuscular triglyceride concentrations
than do Western populations (10). It is suggested that
intramuscular triglycerides may vary from population
to population as seen in Asian Indians having higher
levels of triglycerides compared to Western counterparts
with and without diabetes, suggesting a possible differ-
ence in the association of insulin resistance and diabetes
in this population (8). Moreover, plasma triglycerides
and non-muscle triglycerides are strongly associated with
insulin sensitivity (11).
A pathophysiological link has been shown between
obstructive sleep apnoea and excess visceral fat, indepen-
dent of overall body fat (12). Obstructive sleep apnoea
might bedirectly relatedtoinsulinresistancein bothobese
and non-obese people (12). Physical inactivity and sleep
deprivation might also be contributing factors for manyof
the inflammatory, oxidative, endothelial and coagulation
abnormalities that are associated with phenotype hypoth-
eses, which seem to apply to Asian populations.
Offspring of women who are obese or have diabetes
are at an increased risk of diabetes and other cardiometa-
bolic complications (1315). In view of the increase in
childhood obesity and increasing number of women with
young-onset diabetes in most countries, including Libya,
this link will further exacerbate the situation by creating
a vicious cycle of diabetes begetting diabetes.
The mechanism underlying such transgenerational
inheritance of disease risk is under intense investigation;
it is thought to involve epigenetic silencing of target
genes via methylation or histone modification during
development, resulting in a mismatch between the meta-
bolic phenotype that was programmed during deve-
lopment and the nutritionally rich adult environment
(Fig. 3) (12). Again, this mismatch might be most
pronounced in countries that are undergoing the most
rapid economic development. Improved understanding of
the effect of maternal imprinting phenotype hypotheses
may also apply to Libyan populations.
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Fig. 2. Pathogenesis of diabetes mellitus-twin cycle model.
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in obesity pandemic leading to diabetes is illustrated in
Fig. 3.
The little scientific data available regarding diabetes
in Libya (1621) warn of the possibility of a diabetic
pandemic that warrants an institution of a National
Diabetic Control Policy.
A co-ordinated study related to obesity and obesity-
related diseases needs to be planned and undertaken. Such
a study could focus on: (1) predisposing factors including
perinatal development, ageing, genetic and epigenetic
influences; (2) certain cellular burners explained by the
role of nutrient signals, their influences on transcription
factors involved in lipogenesis, mitochondrial generation
of reactive oxygen species (ROS) including the role of
brown adipose tissue; (3) the role of central nervous
system (CNS) regulating food intake and energy expendi-
ture; (4) a greater understanding of the role of adipose
tissue, its developmental aspects, adipocyte size and
number, secretion of adipocytokines like adiponectin,
Fig. 3. Possible inﬂuence of genetic, metabolomics, environmental factors on the development progression of obesity to clinical
diabetes mellitus.
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necrosis factor a (TNF a), metabolic dynamics of fat
storage and release including insulin resistance (2224)
and the pathological effect of visceral adiposity (abdom-
inal obesity) (4).
These studies, in combination with environmental
and metabolic aspects of obesity, will help to devise
ways and means to regulate energy balance and weight
regulation. The results of such studies will help to
formulate therapeutic measures to fight obesity and
obesity-related problems. This will help translate the
findings of such studies to prevent the progression of
obesity towards the precipitation of clinical diabetes in
Libya, a society with high levels of consanguineous
marriage.
Conclusion
A national road map, designed with such factors as
those explained in Fig. 3, will help give direction and
devise research methods to study obesity and obesity-
related disorders in Libya. As obesity threatens the health
of a community, particularly children and young adults,
its sociological aspect mandates planning to prevent
such precipitation of non-communicable diseases like
diabetes, hypertension and cardiovascular diseases.
Dhastagir S. Sheriff
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